Observational studyFuture oncology (London, England)2025

Long-term safety and effectiveness of ruxolitinib in Japanese patients with polycythemia vera: a post-marketing study.

Tomoko Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.